Clinical bottom line
Urinary incontinence (UI) in older adults with cognitive impairment poses unique management challenges due to overlapping functional, cognitive, and behavioral factors. Current evidence supports a multimodal approach prioritizing non-pharmacologic lifestyle and behavioral interventions tailored to cognitive status, with careful consideration of pharmacologic risks, particularly antimuscarinic agents that may worsen cognition. Skin care to prevent incontinence-associated dermatitis is essential. Emerging digital cognitive and continence training tools show promise but require further validation. Clinicians should individualize management plans balancing symptom control, cognitive safety, and quality of life.
What the evidence shows
Urinary incontinence is common among older adults with cognitive impairment, including mild cognitive impairment (MCI) and dementia, and is associated with increased caregiver burden and institutionalization risk (Jonasson et al., 2016). Behavioral and lifestyle interventions remain first-line management, emphasizing prompted voiding, pelvic floor muscle training, and environmental modifications. Talley et al. (2025) reviewed recent evidence supporting these approaches in frail older adults, highlighting that interventions adapted to cognitive limitations can reduce incontinence episodes and improve continence-related quality of life.
Pharmacologic treatment options are limited by safety concerns. Antimuscarinic agents, commonly used for overactive bladder symptoms, have been linked to cognitive decline in older adults. Huang et al. (2026) conducted a population-based study in adults aged 75 and older with UI or overactive bladder symptoms, finding that bladder antimuscarinic use was associated with increased risk of cognitive impairment, underscoring the need for caution in this population.
Skin care management is critical to prevent incontinence-associated dermatitis, which can exacerbate morbidity in cognitively impaired older adults. Chan et al. (year unknown) provide evidence-based guidelines emphasizing gentle cleansing, moisture barrier application, and regular skin assessment to maintain skin integrity and reduce infection risk.
Innovative digital interventions integrating cognitive and continence training have been piloted. Ghasemi et al. (2019) described "Mr Dustman," a multitasking digital game designed for older adults with MCI and UI, aiming to improve cognitive function and continence through engaging tasks. While promising, such interventions remain preliminary and warrant further clinical trials.
Caveats and uncertainty
Most evidence derives from heterogeneous populations with varying degrees of cognitive impairment, limiting generalizability. Behavioral interventions require caregiver involvement and may be less effective in advanced dementia stages. The risk-benefit profile of pharmacologic agents, especially antimuscarinics, remains incompletely defined, with potential confounding by indication in observational studies like Huang et al. (2026). Digital interventions are in early development phases with limited sample sizes and lack long-term efficacy data.
Moreover, the interplay between diabetes, cognitive impairment, and UI complicates management, as highlighted by DuBeau (2007), but recent targeted studies in this subgroup are lacking. Skin care guidelines are based largely on expert consensus and require adaptation to individual patient needs and resource availability.
How this may change practice
Clinicians managing UI in cognitively impaired older adults should prioritize non-pharmacologic, individualized behavioral interventions with caregiver education and support. Pharmacologic treatments, particularly antimuscarinics, should be prescribed cautiously, considering cognitive risks and alternative therapies. Routine skin care protocols to prevent dermatitis should be integrated into care plans.
Emerging digital tools may augment traditional therapies but should be considered experimental until validated by robust clinical trials. Multidisciplinary collaboration involving geriatrics, urology, nursing, and rehabilitation services is essential to optimize outcomes.
This evidence digest highlights the need for ongoing research to refine intervention strategies tailored to cognitive status and to develop safe, effective pharmacologic options.